肿瘤营养市场规模、份额和成长分析（按癌症类型、营养素类型、配方、通路、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，肿瘤营养市场规模将达到 24.2 亿美元，到 2025 年将达到 26.3 亿美元，到 2033 年将达到 52.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.9%。

癌症营养市场正经历强劲增长，这主要得益于癌症发病率的上升以及人们对营养在癌症治疗中关键作用认识的不断加深。这一增长主要源于接受化疗和放疗等治疗的癌症患者数量的快速增加，而这些治疗可能导致严重的营养缺乏。专业的饮食和营养干预对于症状管理、体重维持和改善治疗效果至关重要。此外，人们对营养在降低癌症风险和促进整体健康方面潜在作用的认识不断提高，也推动了市场需求。主要产业参与者正积极投资研发，以提供创新产品和服务，满足癌症患者独特的营养需求。

肿瘤营养市场驱动因素

推动肿瘤营养市场发展的关键因素之一是全球癌症发生率的不断上升。由于癌症影响众多人群，许多患者面临营养挑战和非自愿性体重下降，这些挑战和体重下降既由疾病本身引起，也与化疗和放疗等治疗的副作用有关。肿瘤营养解决方案对于提供必需营养素、减轻治疗副作用以及改善癌症患者的整体健康状况和生活品质至关重要。此外，人们越来越认识到支持性治疗（尤其是营养治疗）在癌症治疗中的重要作用，整体推动了对专业产品和服务的需求。

肿瘤营养市场的限制因素

癌症营养市场的主要阻碍因素是专为癌症患者设计的营养产品价格高。这些产品经过精心研发，旨在满足每位癌症患者独特的营养需求，因此研发、生产和严格的品管措施都增加了成本。此外，对个人化营养方案和咨询服务的需求进一步推高了成本，并降低了这些产品的可及性。这种经济障碍会阻碍患者的负担能力，尤其对于低收入社区的患者而言，会限制他们在治疗期间获得所需营养支持的能力。

肿瘤营养市场趋势

肿瘤营养市场正加速向个人化营养干预转型，以满足癌症患者的特定需求。这一趋势凸显了营养在促进康復和控制癌症症状的重要性。利用基因谱分析和生物标记分析等先进诊断技术，医疗专业人员能够识别与特定癌症类型和治疗方案相关的独特营养缺乏和需求。个人化营养策略旨在优化饮食摄取、增强免疫功能、减轻治疗相关副作用，并最终提高患者的整体生活品质。这种向精准、个人化营养的转变，标誌着肿瘤领域对整体照护的接受度正在不断提高。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究

全球肿瘤营养市场规模（依癌症类型划分）及复合年增长率（2026-2033 年）

• 消化器官系统癌症
• 肺癌
• 乳癌
• 血癌
• 肝癌
• 其他的

全球肿瘤营养市场规模（依营养类型划分）及复合年增长率（2026-2033 年）

• 经肠营养
  • 标准配方
  • 疾病特异性配方
• 肠外营养
  • 全静脉营养（TPN）
  • 周边静脉营养（PPN）

全球肿瘤营养品市场规模（按配方和复合年增长率划分）（2026-2033 年）

• 粉末
• 液体
• 药片

全球肿瘤营养品市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 医院药房
• 零售药房
• 网路药房

全球肿瘤营养市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 居家医疗环境
• 专科诊所

全球肿瘤营养市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Nestle Health Science（Switzerland）
• Abbott Laboratories（USA）
• Danone SA（France）
• Fresenius Kabi AG（Germany）
• B. Braun Melsungen AG（Germany）
• Mead Johnson Nutrition Company（USA）
• Hormel Foods Corporation（USA）
• Meiji Holdings Co., Ltd.（Japan）
• Victus, Inc.（USA）
• Global Health Products, Inc.（USA）
• Nutritional Medicinals, LLC（USA）
• Kate Farms（USA）
• Ajinomoto Co., Inc.（Japan）
• Abbott Nutrition（USA）
• Danone Nutricia（Netherlands）
• Fresenius SE & Co. KGaA（Germany）
• Baxter International Inc.（USA）
• Nutritional Resources Inc.（USA）

结论与建议

Oncology Nutrition Market size was valued at USD 2.42 Billion in 2024 and is poised to grow from USD 2.63 Billion in 2025 to USD 5.21 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The oncology nutrition market is experiencing robust expansion, fueled by the rising incidence of cancer and an increasing understanding of the critical role nutrition plays in cancer treatment. This growth is largely attributed to the surge in cancer patients undergoing therapies like chemotherapy and radiation, which can lead to significant nutritional deficiencies. Specialized diets and nutritional interventions are essential for managing symptoms, preserving weight, and enhancing treatment outcomes for these patients. Additionally, heightened awareness regarding nutrition's potential to mitigate cancer risks and promote overall health is bolstering market demand. Key industry players are actively investing in research and development to launch innovative products and services tailored to meet the unique nutritional requirements of cancer patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oncology Nutrition Market Segments Analysis

Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oncology Nutrition Market

A significant factor propelling the oncology nutrition market is the rising incidence of cancer globally. As cancer affects a large number of individuals, many patients face nutritional challenges and unintended weight loss, stemming both from the illness and the adverse effects of treatments like chemotherapy and radiation. Oncology nutrition solutions are essential in delivering necessary nutrients, alleviating treatment side effects, and enhancing the general health and quality of life for those undergoing cancer therapy. Additionally, there is an increasing acknowledgment of the critical role that supportive care, particularly nutritional therapy, plays in the overall management of cancer, which further stimulates the demand for these specialized products and services.

Restraints in the Oncology Nutrition Market

A major constraint in the oncology nutrition market is the elevated pricing of specialized nutrition products tailored for cancer patients. These products are meticulously formulated to meet the distinct nutritional requirements of individuals undergoing cancer treatment, resulting in increased costs associated with research and development, production, and stringent quality control measures. Furthermore, the necessity for individualized nutrition plans and personalized counseling services exacerbates the expense, making these products less accessible. This financial barrier can hinder affordability, particularly impacting patients in lower-income areas, which may limit their ability to obtain essential nutrition support during treatment.

Market Trends of the Oncology Nutrition Market

The Oncology Nutrition market is increasingly witnessing a shift towards personalized nutrition interventions tailored to the specific needs of cancer patients. This trend highlights the critical role of nutrition in enhancing recovery and managing cancer symptoms. By leveraging advanced diagnostic techniques, such as genetic profiling and biomarker analysis, healthcare professionals can identify unique nutritional deficiencies and requirements relative to individual cancer types and treatment plans. Personalized nutrition strategies aim to optimize dietary intake, bolster immune function, alleviate treatment-related side effects, and ultimately improve the overall quality of life for patients. This movement towards precision and individualized nutrition signifies a broader embrace of holistic care within oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Oncology Nutrition Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Gastrointestinal Cancer
• Lung Cancer
• Breast Cancer
• Blood Cancer
• Liver Cancer
• Others

Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2026-2033)

• Market Overview
• Enteral Nutrition
  • Standard Formulas
  • Disease-Specific Formulas
• Parenteral Nutrition
  • Total Parenteral Nutrition (TPN)
  • Peripheral Parenteral Nutrition (PPN)

Global Oncology Nutrition Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Powder
• Liquid
• Tablet

Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oncology Nutrition Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare Settings
• Specialty Clinics

Global Oncology Nutrition Market Size & CAGR (2026-2033)

• North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
  • US
  • Canada
• Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mead Johnson Nutrition Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hormel Foods Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meiji Holdings Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Victus, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Health Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutritional Medicinals, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kate Farms (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone Nutricia (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutritional Resources Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations